Orthofix reaches agreement “in principle” with SEC over Brazil FCPA allegations

Texas-based medical device company Orthofix has set aside US$6.1 million in anticipation of a settlement with the US Securities and Exchange Commission over allegations of improper payments at its Brazilian subsidiary, Orthofix do Brasil.

Unlock unlimited access to all Global Investigations Review content